title: Pegvisomant-induced lipohypertrophy: report of a case with histopathology.
authors.forename: Monica
authors.initials: M
authors.lastname: Marazuela
authors.forename: Esteban
authors.initials: E
authors.lastname: Daudén
authors.forename: Elena
authors.initials: E
authors.lastname: Ocón
authors.forename: Dolores
authors.initials: D
authors.lastname: Moure
authors.forename: Lia
authors.initials: L
authors.lastname: Nattero
mesh_terms: D000005:Abdomen; D000172:Acromegaly / Q000188:drug therapy; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008060:Lipodystrophy / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged
chemical_list: D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; C406545:pegvisomant